PhageVax
Chemicals & Related Products · Ohio, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
855 Sharon Valley Rd 101, Newark, Ohio, ...Phone Number
(740) 366-9013Website
www.phagevax.comRevenue
<$5 MillionIndustry
About PhageVax
PhageVax Org Chart
Is PhageVax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if PhageVax is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PhageVax had a recent Job posting/layoffs
Check if PhageVax has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when PhageVax launches new products
Funding: Get notified immidiatlly once PhageVax has new funding data
Earning: See what the market has to say on PhageVax recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at PhageVax
Website visits: Recent activity has been detected on your website
PhageVax, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at PhageVax
Find 2 more new buyers
Compare Similar Companies to PhageVax
Compare insights from companies similar to PhageVax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PhageVax is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PhageVax is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PhageVax.
PhageVax Tech Stack
A closer look at the technologies used by PhageVax
Top Chemicals & Related Products Companies
Frequently Asked Questions Regarding PhageVax
PhageVax, Inc. specializes in developing innovative vaccine technologies using bacteriophage T4 nanoparticles for rapid response to infectious diseases, including COVID-19 and influenza. Their platform enables the creation of needle-free, mucosal vaccines that can be produced quickly and stored without refrigeration, addressing critical challenges... Read More